• 60% of patients with genital herpes will experience recurrences. Recurrent lesions in the

perianal area tend to be more numerous and persists longer than their oral HSV-1

counterparts.

Herpes Simplex Encephalitis

• Herpes Simplex encephalitis is one of the most serious complications of herpes simplex

disease. There are two forms:

• Neonatal – there is global involvement and the brain is almost liquefied. The mortality rate

approaches 100%.

• Focal disease – the temporal lobe is most commonly affected. This form of the disease

appears in children and adults. It is possible that many of these cases arise from reactivation

of virus. The mortality rate is high (70%) without treatment.

• It is of utmost importance to make a diagnosis of HSE early. It is general practice that IV

acyclovir is given in all cases of suspected HSE before laboratory results are available.

267

 Arranged by Sarah Mohssen

Section II - Virology By Dr. Kareem Lilo

Other Manifestations

• Disseminated herpes simplex are much more likely to occur in immunocompromised

individuals. The widespread vesicular resembles that of chickenpox. Many organs other than

the skin may be involved e.g. liver, spleen, lungs, and CNS.

• Other cutaneous manifestations include

- eczema herpeticum which is potentially a serious disease that occurs in patients with

eczema.

- Herpetic whitlow which arise from implantation of the virus into the skin and typically affect

the fingers.

- “zosteriform herpes simplex". This is a rare presentation of herpes simplex where HSV

lesions appear in a dermatomal distribution similar to herpes zoster.

Laboratory Diagnosis

1. Direct Detection

- Electron microscopy of vesicle fluid - rapid result but cannot distinguish between HSV and

VZV

- Immunofluorescence of skin scrappings - can distinguish between HSV and VZV

- PCR - now used routinely for the diagnosis of herpes simplex encephalitis

2. Virus Isolation

- HSV-1 and HSV-2 are among the easiest viruses to cultivate. It usually takes only 1 - 5 days

for a result to be available.

3. Serology

- Not that useful in the acute phase because it takes 1-2 weeks for before antibodies appear

after infection. Used to document to recent infection.

A-Cytopathic Effect of HSV in cell culture: Note the

ballooning of cells. (Linda Stannard, University of Cape

Town, S.A)

B-Positive immunofluorescence test for HSV antigen in epithelial

cell. (Virology Laboratory, New-Yale Haven Hospital(

A B

Figure (2-29)

268

 Arranged by Sarah Mohssen

Section II - Virology By Dr. Kareem Lilo

Management

At present, there are only a few indications of antiviral chemo-therapy, with the high cost of antiviral

drugs being a main consideration. Generally, antiviral chemotherapy is indicated where the primary

infection is especially severe, where there is dissemination, where sight is threatened, and herpes

simplex encephalitis.

Acyclovir – this the drug of choice for most situations at present. It is available in a number of

formulations:-

- I.V. (HSV infection in normal and immunocompromised patients)

- Oral (treatment and long term suppression of mucocutaneous herpes and prophylaxis of

HSV in immunocompromised patients)

- Cream (HSV infection of the skin and mucous membranes)

- Ophthalmic ointment

Famciclovir and valacyclovir – oral only, more expensive than acyclovir.

Other older agents – e.g. idoxuridine, trifluorothymidine, Vidarabine (ara-A).

• These agents are highly toxic and is suitable for topical use for opthalmic infection only

Varicella- Zoster Virus

Properties

• Belong to the alphaherpesvirus subfamily of herpesviruses

• Double stranded DNA enveloped virus

• Genome size 125 kbp, long and short fragments with a total of 4 isometric forms.

• One antigenic serotype only, although there is some cross reaction with HSV.

Epidemiology

• Primary varicella is an endemic disease. Varicella is one of the classic diseases of childhood,

with the highest prevalence occurring in the 4 - 10 years old age group.

• Varicella is highly communicable, with an attack rate of 90% in close contacts.

• Most people become infected before adulthood but 10% of young adults remain susceptible.

• Herpes zoster, in contrast, occurs sporadically and evenly throughout the year.

Pathogenesis

• The virus is thought to gain entry via the respiratory tract and spreads shortly after to the

lymphoid system.

• After an incubation period of 14 days, the virus arrives at its main target organ, the skin.

269

 Arranged by Sarah Mohssen

Section II - Virology By Dr. Kareem Lilo

• Following the primary infection, the virus remains latent in the cerebral or posterior root

ganglia. In 10 - 20% of individuals, a single recurrent infection occurs after several decades.

• The virus reactivates in the ganglion and tracks down the sensory nerve to the area of the

skin innervated by the nerve, producing a varicellaform rash in the distribution of a

dermatome.

Varicella

• Primary infection results in varicella (chickenpox)

• Incubation period of 14-21 days

• Presents fever, lymphadadenopathy. a widespread vesicular rash.(Figure2-29)

• The features are so characteristic that a diagnosis can usually be made on clinical grounds

alone.

• Complications are rare but occurs more frequently and with greater severity in adults and

immunocompromised patients.

• Most common complication is secondary bacterial infection of the vesicles.

• Severe complications which may be life threatening include viral pneumonia, encephalititis,

and haemorrhagic chickenpox.

Herpes Zoster (Shingles)

• Herpes Zoster mainly affect a single dermatome of the skin (Figure2-30).

• It may occur at any age but the vast majority of patients are more than 50 years of age.

• The latent virus reactivates in a sensory ganglion and tracks down the sensory nerve to the

appropriate segment.

• There is a characteristic eruption of vesicles in the dermatome which is often accompanied by

intensive pain which may last for months (postherpetic neuralgia)

• Herpes zoster affecting the eye and face may pose great problems.

Figure(2-29) Rash of Chickenpox

270

 Arranged by Sarah Mohssen

Section II - Virology By Dr. Kareem Lilo

• As with varicella, herpes zoster in a far greater problem in immunocompromised patients in

whom the reactivation occurs earlier in life and multiple attacks occur as well as

complications.

• Complications are rare and include encephalitis and disseminated herpes zoster.

Congenital VZV Infection

• 90% of pregnant women already immune, therefore primary infection is rare during

pregnancy.

• Primary infection during pregnancy carries a greater risk of severe disease, in particular

pneumonia.

First 20 weeks of Pregnancy

- Up to 3% chance of transmission to the fetus, recognised congenital varicella syndrome;

1. Scarring of skin

2. Hypoplasia of limbs

3. CNS and eye defects

4. Death in infancy normal

Laboratory Diagnosis

The clinical presentations of varicella or zoster are so characteristic that laboratory confirmation is

rarely required. Laboratory diagnosis is required only for atypical presentations, particularly in the

immunocompromised.

Virus Isolation - rarely carried out as it requires 2-3 weeks for a results.

Figure(2-30) Shingles

271

 Arranged by Sarah Mohssen

Section II - Virology By Dr. Kareem Lilo

Direct detection - electron microscopy may be used for vesicle fluids but cannot distinguish between

HSV and VZV. Immunofluorescense on skin scrappings can distinguish between the two.

Serology - the presence of VZV IgG is indicative of past infection and immunity. The presence of

IgM is indicative of recent primary infection.

Management

• Uncomplicated varicella is a self limited disease and requires no specific treatment.

However, acyclovir had been shown to accelerate the resolution of the disease and is

prescribed by some doctors.

• Acyclovir should be given promptly immunocompromised individuals with varicella

infection and normal individuals with serious complications such as pneumonia and

encephalitis.

• herpes zoster in a healthy individual is not normally a cause for concern. The main problem

is the management of the postherpetic neuralgia.

• The International Herpes Management Forum recommends that antiviral therapy should be

offered routinely to all patients over 50 years of age presenting with herpes zoster.

• Three drugs can be used for the treatment of herpes zoster: acyclovir, valicyclovir, and

famciclovir. There appears to be little difference in efficacy between them.

Prevention

• Preventive measures should be considered for individuals at risk of contracting severe

varicella infection e.g. leukaemic children, neonates, and pregnant women

• Where urgent protection is needed, passive immunization should be given. Zoster

immunoglobulin (ZIG) is the preparation of choice but it is very expensive. Where ZIG is not

available, HNIG should be given instead.

• A live attenuated vaccine is available. There had been great reluctance to use it in the past,

especially in immunocompromised individuals since the vaccine virus can become latent and

reactivate later on.

• However, recent data suggests that the vaccine is safe, even in children with leukaemia

provided that they are in remission.

• It is highly debatable whether universal vaccination should be offered since chickenpox and

shingles are normally mild diseases.

Cytomegalovirus

Properties

1. Belong to the betaherpesvirus subfamily of herpesviruses

2. double stranded DNA enveloped virus

272

 Arranged by Sarah Mohssen

Section II - Virology By Dr. Kareem Lilo

3. Nucleocapsid 105nm in diameter, 162 capsomers

4. The structure of the genome of CMV is similar to other herpesviruses, consisting of long and

short segments which may be orientated in either direction, giving a total of 4 isomers.

5. A large no. of proteins are encoded for, the precise number is unknown.

Epidemiology

• CMV is one of the most successful human pathogens, it can be transmitted vertically or

horizontally usually with little effect on the host.

• Transmission may occur in utero, perinatally or postnatally. Once infected, the person carries

the virus for life which may be activated from time to time, during which infectious virions

appear in the urine and the saliva.

• Reactivation can also lead to vertical transmission. It is also possible for people who have

experienced primary infection to be reinfected with another or the same strain of CMV, this

reinfection does not differ clinically from reactivation.

.

Pathogenesis

• Once infected, the virus remains in the person for life and my be reactivated from time to

time, especially in immunocompromised individuals.

• The virus may be transmitted in utero, perinatally, or postnatally. Perinatal transmission

occurs.

• Perinatal infection is acquired mainly through infected genital secretions, or breast milk.

Overall, 2 - 10% of infants are infected by the age of 6 months worldwide. Perinatal infection

is thought to be 10 times more common than congenital infection.

• Postnatal infection mainly occurs through saliva. Sexual transmission may occur as well as

through blood and blood products and transplanted organ.

Laboratory Diagnosis (1)

Direct detection

• biopsy specimens may be examined histologically for CMV inclusion antibodies or for the

presence of CMV antigens. However, the sensitivity may be low.

• The pp65 CMV antigenaemia test is now routinely used for the rapid diagnosis of CMV

infection in immunocompromised patients.

• PCR for CMV-DNA is used in some centers but there may be problems with

interpretation(Figure 2-31).

273

 Arranged by Sarah Mohssen

Section II - Virology By Dr. Kareem Lilo

Laboratory Diagnosis (2)

Virus Isolation

• conventional cell culture is regarded as gold standard but requires up to 4 weeks for result.

• More useful are rapid culture methods such as the DEAFF test which can provide a result in

24-48 hours.

Serology

- the presence of CMV IgG antibody indicates past infection.

- The detection of IgM is indicative of primary infection although it may also be found in

immunocompromised patients with reactivation.

Prevention

- No licensed vaccine is available. There is a candidate live attenuated vaccine known as the

Towne strain but there are concerns about administering a live vaccine which could become

latent and reactivates.

- Prevention of CMV disease in transplant recipients is a very complicated subject and varies

from center to center. It may include the following measures.

• Screening and matching the CMV status of the donor and recipient

• Use of CMV negative blood for transfusions

• Administration of CMV immunoglobulin to seronegative recipients prior to transplant

• Give antiviral agents such as acyclovir and ganciclovir prophylactically.

Epstein-Barr Virus

Epstein-Barr Virus (EBV)

Figure (2-31)CMV pp65 detected in nuclei peripheral blood neutrophils

274

 Arranged by Sarah Mohssen

Section II - Virology By Dr. Kareem Lilo

• Belong to the gammaherpesvirus subfamily of herpesviruses

• Nucleocapsid 100 nm in diameter, with 162 capsomers

• Membrane is derived by budding of immature particles through cell membrane and is

required for infectivity.

• Genome is a linear double stranded DNA molecule with 172 kbp

• The viral genome does not normally integrate into the cellular DNA but forms circular

episomes which reside in the nucleus.

• The genome is large enough to code for 100 - 200 proteins but only a few have been

identified.

Epidemiology

• Two epidemiological patterns are seen with EBV.

• In developed countries, 2 peaks of infection are seen : the first in very young preschool

children aged 1 - 6 and the second in adolescents and young adults aged 14 - 20 Eventually

80-90% of adults are infected.

• In developing countries, infection occurs at a much earlier age so that by the age of two, 90%

of children are seropositive.

• The virus is transmitted by contact with saliva, in particularly through kissing.

Pathogenesis

• Once infected, a lifelong carrier state develops whereby a low grade infection is kept in check

by the immune defenses.

• Low grade virus replication and shedding can be demonstrated in the epithelial cells of the

pharynx of all seropositive individuals.

• EBV is able to immortalize B-lymphocytes in vitro and in vivo

• Furthermore a few EBV-immortalized B-cells can be demonstrated in the circulation which

are continually cleared by immune surveillance mechanisms.

• EBV is associated with several very different diseases where it may act directly or one of

several co-factors.

Disease Association

1. Infectious Mononucleosis

2. Burkitt's lymphoma

3. Nasopharyngeal carcinoma

4. Lymphoproliferative disease and lymphoma in the immunosuppressed.

5. X-linked lymphoproliferative syndrome

275

 Arranged by Sarah Mohssen

Section II - Virology By Dr. Kareem Lilo

6. Chronic infectious mononucleosis

7. Oral leukoplakia in AIDS patients

8. Chronic interstitial pneumonitis in AIDS patients.

Infectious Mononuclosis

• Primary EBV infection is usually subclinical in childhood. However in adolescents and

adults, there is a 50% chance that the syndrome of infectious mononucleosis (IM) will

develop.

• IM is usually a self-limited disease which consists of fever, lymphadenopathy and

splenomegaly. In some patients jaundice may be seen which is due to hepatitis. Atypical

lymphocytes are present in the blood.

• Complications occur rarely but may be serious e.g. splenic rupture, meningoencephalitis,

and pharyngeal obstruction.

• In some patients, chronic IM may occur where eventually the patient dies of

lymphoproliferative disease or lymphoma.

• Diagnosis of IM is usually made by the heterophil antibody test and/or detection of EBV

IgM.

• There is no specific treatment.

Burkitt’s Lymphoma (1)

• Burkitt's lymphoma (BL) occurs endemically in parts of Africa (where it is the commonest

childhood tumour) and Papua New Guinea. It usually occurs in children aged 3-14 years. It

respond favorably to chemotherapy.

• It is restricted to areas with holoendemic malaria. Therefore it appears that malaria infection

is a cofactor.

• Multiple copies of EBV genome and some EBV antigens can be found in BL cells and patients

with BL have high titres of antibodies against various EBV antigens.

Burkitt’s Lymphoma (2)

• BL cells show a reciprocal translocation between the long arm of chromosome 8 and

chromosomes 14, 2 or 22.

• This translocation result in the c-myc oncogene being transferred to the Immunoglobulin

gene regions. This results in the deregulation of the c-myc gene. It is thought that this

translocation is probably already present by the time of EBV infection and is not caused by

EBV.

276

 Arranged by Sarah Mohssen

Section II - Virology By Dr. Kareem Lilo

• Sporadic cases of BL occur, especially in AIDS patients which may or may not be associated

with EBV.

• In theory BL can be controlled by the eradication of malaria (as has happened in Papua New

Guinea) or vaccination against EBV.

Immunocompromised Patients

• After primary infection, EBV maintains a steady low grade latent infection in the body.

Should the person become immunocompromised, the virus will reactivate. In a few cases,

lymphoproliferative lesions and lymphoma may develop. These lesions tend to be

extranodal and in unusual sites such as the GI tract or the CNS.

• Transplant recipients e.g. renal - EBV is associated with the development of

lymphoproliferative disease and lymphoma.

• AIDS patients - EBV is associated with oral leukoplakia and with various Non-Hodgekin’s

lymphoma.

• Ducan X-linked lymphoproliferative syndrome - this condition occurs exclusively in males

who had inherited a defective gene in the X-chromosome . This condition accounts for half

of the fatal cases of IM.

Diagnosis

• Acute EBV infection is usually made by the heterophil antibody test and/or detection of antiEBV VCA IgM.

• Cases of Burkitt’s lymphoma should be diagnosed by histology. The tumour can be stained

with antibodies to lambda light chains which should reveal a monoclonal tumour of B-cell

origin. In over 90% of cases, the cells express IgM at the cell surface.

• Cases of NPC should be diagnosed by histology.

• The determination of the titre of anti-EBV VCA IgA in screening for early lesions of NPC and

also for monitoring treatment.

• A patient with with non-specific ENT symptoms who have elevated titres of EBV IgA should

be given a thorough examination.

Vaccination

• A vaccine against EBV which prevents primary EBV infection should be able to control both

BL and NPC.

277

 Arranged by Sarah Mohssen

Section II - Virology By Dr. Kareem Lilo

• Such a vaccine must be given early in life. Such a vaccine would also be useful in

seronegative organ transplant recipients and those developing severe IM, such as the male

offspring of X-linked proliferative syndrome carriers.

• The vaccine should not preferably be a subunit vaccine since there is a danger that a live

vaccine may still have tumorigenic properties.

• The antigen chosen for vaccine development is the MA antigen gp 340/220 as antibodies

against this antigen are virus neutralizing.

• This vaccine is being tried in Africa.

Other Human Herpes Viruses

Properties of HHV-6 and 7

• Belong to the betaherpesvirus subfamily of herpesviruses

• Double stranded DNA genome of 170 kbp

• The main target cell is the T-lymphocyte, although B-lymphocytes may also be infected.

• HHV-6 and HHV-7 share limited nucleotide homology and antigenic cross-reactivity.

• It is thought that HHV-6 and HHV-7 are related to each other in a similar manner to HSV-1

and HSV-2.

Epidemiology and Pathogenesis

• HHV-6 and HHV-7 are ubiquitous and are found worldwide.

• They are transmitted mainly through contact with saliva and through breast feeding.

• HHV-6 and HHV-7 infection are acquired rapidly after the age of 4 months when the effect

of maternal antibody wears off.

• By the time of adulthood, 90-99% of the population had been infected by both viruses.

• Like other herpesviruses, HHV-6 and HHV-7 remains latent in the body after primary

infection and reactivates from time to time.

Clinical Manifestations (1)

• Primary HHV-6 infection is associated with Roseala Infantum, which is a classical disease of

childhood.

• Most cases occur in infants between the ages of 4 months and two years.

• A spiking fever develops over a period of 2 days followed by a mild rash. The fever is high

enough to cause febrile convulsions.

• There are reports that the disease may be complicated by encephalitis.

278

 Arranged by Sarah Mohssen

Section II - Virology By Dr. Kareem Lilo

Clinical Manifestations (2)

• If primary infection is delayed until adulthood, there is a small chance that an infectious

mononucleosis-like disease may develop in a similar manner to EBV and CMV.

• There is no firm evidence linking HHV-6 to lymphomas or lymphoproliferative diseases.

• There is no firm disease association with HHV-7 at present.

• Although both viruses may be reactivated in immunocompromised patients, it is yet

uncertain whether they cause significant disease since CMV is almost invariably present.

Diagnosis and Management

• Rosela Infantum has a very characteristic presentation and a diagnosis can usually be made

on clinical grounds alone.

• Therefore very few virology laboratories offer a diagnostic service for HHV-6 or HHV-7

infection.

• The technique for virus isolation is complicated and thus not practicable as a routine

diagnostic procedure.

• Therefore serology is the mainstay of diagnosis where specific IgM and IgG are detected.

• There is no specific antiviral treatment for HHV-6 infection.

Human Herpes Virus 8

• Belong to the gammaherpesviruses subfamily of herpesviruses

• Originally isolated from cells of Kaposi’s sarcoma (KS)

• Now appears to be firmly associated with Kaposi’s sarcoma as well as some lesser known

malignancies such as Castleman’s disease and primary effusion lymphomas(Figure 2-32)

• HHV-8 DNA is found in almost 100% of cases of Kaposi’s sarcoma

• Most patients with KS have antibodies against HHV-8

• The seroprevalence of HHV-8 is low among the general population but is high in groups of

individuals susceptible to KS, such as homosexuals.

• Unlike other herpesviruses, HHV-8 does not have a ubiquitous distribution.

279

 Arranged by Sarah Mohssen

Section II - Virology By Dr. Kareem Lilo

Figure (2-32) Diseases caused by Herpesvirus

Comments

Search This Blog

Archive

Show more

Popular posts from this blog

TRIPASS XR تري باس

CELEPHI 200 MG, Gélule

ZENOXIA 15 MG, Comprimé

VOXCIB 200 MG, Gélule

Kana Brax Laberax

فومي كايند

بعض الادويه نجد رموز عليها مثل IR ، MR, XR, CR, SR , DS ماذا تعني هذه الرموز

NIFLURIL 700 MG, Suppositoire adulte

Antifongiques مضادات الفطريات

Popular posts from this blog

علاقة البيبي بالفراولة بالالفا فيتو بروتين

التغيرات الخمس التي تحدث للجسم عند المشي

إحصائيات سنة 2020 | تعداد سكَان دول إفريقيا تنازليا :

ما هو الليمونير للأسنان ؟

ACUPAN 20 MG, Solution injectable

CELEPHI 200 MG, Gélule

الام الظهر

VOXCIB 200 MG, Gélule

ميبستان

Popular posts from this blog

TRIPASS XR تري باس

CELEPHI 200 MG, Gélule

Popular posts from this blog

TRIPASS XR تري باس

CELEPHI 200 MG, Gélule

ZENOXIA 15 MG, Comprimé

VOXCIB 200 MG, Gélule

Kana Brax Laberax

فومي كايند

بعض الادويه نجد رموز عليها مثل IR ، MR, XR, CR, SR , DS ماذا تعني هذه الرموز

NIFLURIL 700 MG, Suppositoire adulte

Antifongiques مضادات الفطريات

Popular posts from this blog

Kana Brax Laberax

TRIPASS XR تري باس

PARANTAL 100 MG, Suppositoire بارانتال 100 مجم تحاميل

الكبد الدهني Fatty Liver

الم اسفل الظهر (الحاد) الذي يظهر بشكل مفاجئ bal-agrisi

SEDALGIC 37.5 MG / 325 MG, Comprimé pelliculé [P] سيدالجيك 37.5 مجم / 325 مجم ، قرص مغلف [P]

نمـو الدمـاغ والتطـور العقـلي لـدى الطفـل

CELEPHI 200 MG, Gélule

أخطر أنواع المخدرات فى العالم و الشرق الاوسط

Archive

Show more